Jacqueline Booth, MD
Plastic Surgery within the Head & Neck · Oak Ridge, TNNPI 1083143671
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $541 of the $792 with a category attached, or 68.4%. 12 manufacturers reported payments, led by Stryker at 35.1% of the total. Reporting peaked in 2019 at $400 and has fallen 62.6% since, to $150 in 2025.
Across 24 payments — averaging $32.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$278
- Medtronic$272
- Regeneron Healthcare Solutions, Inc.$55
- AstraZeneca$41
- Galderma Laboratories, L.p.$24
- Boston Scientific$24
- plus $98 from 6 others
What the payments were for
- Food & beverage$54168%
- Education$25132%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 3 | $278 |
| Medtronic(2 entities) | 8 | $272 |
| Regeneron Healthcare Solutions, Inc. | 2 | $55 |
| AstraZeneca | 2 | $41 |
| Galderma Laboratories, L.p. | 1 | $24 |
| Boston Scientific | 1 | $24 |
| Inspire Medical Systems, Inc. | 1 | $19 |
| Sanofi | 1 | $19 |
| Paratek Pharmaceuticals, Inc. | 1 | $18 |
| Amgen | 1 | $15 |
| Shire North American Group Inc | 1 | $14 |
| Phathom Pharmaceuticals, Inc. | 2 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few plastic surgery within the head & neck providers in Tennesseeto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cephalexin | 169 | $589 |
| Doxycycline Monohydrate | 26 | $558 |
| Doxycycline Hyclate | 30 | $453 |
| Azelastine Hcl | 11 | $206 |
| Mupirocin | 30 | $158 |
| Fluticasone Propionate | 14 | $154 |
| Famotidine | 13 | $51 |
| Tramadol Hcl | 15 | $24 |
Paid to pharmacies, not to this prescriber.
Other plastic surgery within the head & neck in Oak Ridge
- Charles SewallOak Ridge$2K
- John JerniganOak Ridge$43
- Jason HallKnoxville$68K
- James ShireChattanooga$33K
- Eben RosenthalNashville$23K
- James BekenyNashville$10K
- Elizabeth PerkinsNashville$9K
- Howard HammerDickson$7K
- Marc FeeleyNashville$3K
- Richard DepersioPowell$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.